About Perosphere Pharmaceuticals
Perosphere Pharmaceuticals is a company based in Danbury (United States) founded in 2011 was acquired by AMAG Pharma in December 2018.. Perosphere Pharmaceuticals has raised $6.21 million across 1 funding round from investors including AMAG Pharma. Perosphere Pharmaceuticals operates in a competitive market with competitors including Freeline, Keros Therapeutics, Jasper Therapeutics, Disc Medicine and Interius Biotherapeutics, among others.
- Headquarter Danbury, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.21 M (USD)
in 1 rounds
-
Latest Funding Round
$6.21 M (USD), Series A
Feb 04, 2016
- Investors
-
Employee Count
Employee Count
-
Acquired by
AMAG Pharma
(Dec 13, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Perosphere Pharmaceuticals
Perosphere Pharmaceuticals has successfully raised a total of $6.21M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.21 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.2M
-
First Round
First Round
(04 Feb 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2016 | Amount | Series A - Perosphere Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perosphere Pharmaceuticals
Perosphere Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include AMAG Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of anemia based products and imaging agents for cancer and CVD diagnosis
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perosphere Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perosphere Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perosphere Pharmaceuticals Comparisons
Competitors of Perosphere Pharmaceuticals
Perosphere Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freeline, Keros Therapeutics, Jasper Therapeutics, Disc Medicine and Interius Biotherapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed to treat hematologic and musculoskeletal disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of hematologic diseases
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Human plasma-based biopharmaceutical products are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perosphere Pharmaceuticals
Frequently Asked Questions about Perosphere Pharmaceuticals
When was Perosphere Pharmaceuticals founded?
Perosphere Pharmaceuticals was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Perosphere Pharmaceuticals located?
Perosphere Pharmaceuticals is headquartered in Danbury, United States. It is registered at Danbury, Connecticut, United States.
Is Perosphere Pharmaceuticals a funded company?
Perosphere Pharmaceuticals is a funded company, having raised a total of $6.21M across 1 funding round to date. The company's 1st funding round was a Series A of $6.21M, raised on Feb 04, 2016.
What does Perosphere Pharmaceuticals do?
Perosphere Pharmaceuticals is a specialty pharmaceutical company developing candidates that can re-establish normal blood coagulation in patients treated with anticoagulation drugs. Their lead candidate, ciraparantag (PER977) is a small synthetic water soluble NME which is intended for use as a reversal agent for the orally administered direct Factor Xa inhibitors and heparin is undergoing Phase 2 trials. The drug is being tested with anticoagulant products from Daiichi Sankyo, JJ, Bayer, BMS and Pfizer. The drug is FDA Fast Track designated. The company is also developing PER726, a drug targeting patients with status epilepticus (traumatic brain injury and are unresponsive to current therapies.
Who are the top competitors of Perosphere Pharmaceuticals?
Perosphere Pharmaceuticals's top competitors include Keros Therapeutics, Disc Medicine and Freeline.
Who are Perosphere Pharmaceuticals's investors?
Perosphere Pharmaceuticals has 1 investor. Key investors include AMAG Pharma.